Biggest changeYear Ended December 31, Variance % 2024 2023 Revenue $ 2,569,574 $ 2,602,415 $ (32,841) (1) % Costs and expenses: Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) 751,270 760,031 (8,761) (1) % Advertising and marketing 705,787 688,854 16,933 2 % Sales 204,993 213,780 (8,787) (4) % Technology and development 307,274 348,521 (41,247) (12) % General and administrative 435,490 464,659 (29,169) (6) % Goodwill impairment 790,000 — 790,000 n/a Acquisition, integration, and transformation costs 1,743 21,110 (19,367) (92) % Restructuring costs 20,355 16,942 3,413 20 % Amortization of intangible assets 363,365 325,933 37,432 11 % Depreciation of property and equipment 10,183 11,138 (955) (9) % Total costs and expenses 3,590,460 2,850,968 739,492 26 % Loss from operations (1,020,886) (248,553) (772,333) n/m Interest income (57,071) (46,782) (10,289) 22 % Interest expense 23,803 22,282 1,521 7 % Other expense (income), net 6,035 (4,445) 10,480 (236) % Loss before provision for income taxes (993,653) (219,608) (774,045) n/m Provision for income taxes 7,592 760 6,832 n/m Net loss $ (1,001,245) $ (220,368) $ (780,877) n/m Net loss per share, basic and diluted $ (5.87) $ (1.34) $ (4.53) n/m Adjusted EBITDA (1) $ 310,711 $ 328,120 $ (17,409) (5) % ______________________________________ n/m – not meaningful (1) Non-GAAP Financial Measures 64 Table of Contents The following table reconciles net loss, the most directly comparable GAAP measure, to Adjusted EBITDA for the years ended December 31, 2024 and 2023 (in thousands): Year Ended December 31, 2024 2023 Net loss $ (1,001,245) $ (220,368) Add: Provision for income taxes 7,592 760 Other expense (income), net 6,035 (4,445) Interest expense 23,803 22,282 Interest income (57,071) (46,782) Depreciation of property and equipment 10,183 11,138 Amortization of intangible assets 363,365 325,933 Restructuring costs 20,355 16,942 Acquisition, integration, and transformation costs 1,743 21,110 Goodwill impairment 790,000 — Stock-based compensation 145,951 201,550 Adjusted EBITDA $ 310,711 $ 328,120 Integrated Care $ 232,902 $ 191,871 BetterHelp 77,809 136,249 Adjusted EBITDA $ 310,711 $ 328,120 Revenue.
Biggest changeYear Ended December 31, Variance % 2025 2024 Revenue $ 2,529,977 $ 2,569,574 $ (39,597) (2) % Costs and expenses: Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) 771,593 751,270 20,323 3 % Advertising and marketing 653,372 705,787 (52,415) (7) % Sales 194,518 204,993 (10,475) (5) % Technology and development 277,922 307,274 (29,352) (10) % General and administrative 431,891 435,490 (3,599) (1) % Goodwill impairments 71,763 790,000 (718,237) (91) % Acquisition, integration, and transformation costs 9,010 1,743 7,267 n/m Restructuring costs 18,785 20,355 (1,570) (8) % Amortization of intangible assets 350,764 363,365 (12,601) (3) % Depreciation of property and equipment 13,314 10,183 3,131 31 % Total costs and expenses 2,792,932 3,590,460 (797,528) (22) % Loss from operations (262,955) (1,020,886) 757,931 74 % Interest income (36,770) (57,071) 20,301 (36) % Interest expense 19,714 23,803 (4,089) (17) % Other expense (income), net (10,369) 6,035 (16,404) n/m Loss before provision for income taxes (235,530) (993,653) 758,123 76 % Provision for income taxes (35,208) 7,592 (42,800) n/m Net loss $ (200,322) $ (1,001,245) $ 800,923 80 % Net loss per share, basic and diluted $ (1.14) $ (5.87) $ 4.73 81 % Adjusted EBITDA (1) $ 281,095 $ 310,711 $ (29,616) (10) % n/m – not meaningful (1) Non-GAAP Financial Measures 66 Table of Contents The following table reconciles net loss, the most directly comparable GAAP measure, to Adjusted EBITDA for the years ended December 31, 2025 and 2024 (in thousands): Year Ended December 31, 2025 2024 Net loss $ (200,322) $ (1,001,245) Add: Provision for income taxes (35,208) 7,592 Other expense (income), net (10,369) 6,035 Interest expense 19,714 23,803 Interest income (36,770) (57,071) Depreciation of property and equipment 13,314 10,183 Amortization of intangible assets 350,764 363,365 Restructuring costs 18,785 20,355 Acquisition, integration, and transformation costs 9,010 1,743 Goodwill impairments 71,763 790,000 Stock-based compensation 80,414 145,951 Adjusted EBITDA $ 281,095 $ 310,711 Integrated Care $ 239,222 $ 232,902 BetterHelp 41,873 77,809 Adjusted EBITDA $ 281,095 $ 310,711 Revenue.
They also include bank charges, most of the facilities costs including rent, utilities, and facilities maintenance, except for amounts allocated to cost of revenues, as well as therapists recruiting costs, related to BetterHelp, indirect taxes and certain licensed corporate applications. Our general and administrative expenses exclude any allocation of depreciation and amortization.
They also include bank charges, most of the occupancy costs including rent, utilities, and facilities maintenance, except for amounts allocated to cost of revenues, as well as therapists recruiting costs, related to BetterHelp, indirect taxes and certain licensed corporate applications. Our general and administrative expenses exclude any allocation of depreciation and amortization.
For other revenue, which primarily includes virtual healthcare devices, our performance obligation is satisfied when the equipment is provided to the Client and revenue is recognized at a point in time upon shipment. We generally bill for virtual healthcare services on a monthly basis, in advance or in arrears depending on the service, with payment terms generally being 30 days.
For other revenue, which primarily includes virtual care devices, our performance obligation is satisfied when the equipment is provided to the Client and revenue is recognized at a point in time upon shipment. We generally bill for virtual care services on a monthly basis, in advance or in arrears depending on the service, with payment terms generally being 30 days.
For example, a sustained increase in the customer attrition rate related to customers added as a result of the Livongo acquisition could prompt us to reduce our estimate of the remaining useful life of the customer relationships. Should this occur, a one-year reduction to the estimated life would result in an annual increase in amortization expense of approximately $6.0 million.
For example, a sustained increase in the customer attrition rate related to customers added as a result of the Livongo acquisition could prompt us to reduce our estimate of the remaining useful life of the customer relationships. Should this occur, a one-year reduction to the estimated life would result in an annual increase in amortization expense of approximately $7.0 million.
These transformation cost adjustments made to our results do not represent normal, recurring, operating expenses necessary to operate the business but rather, incremental costs incurred in connection with our acquisition and integration activities; • Adjusted EBITDA does not reflect goodwill impairment charges; and 63 Table of Contents • Adjusted EBITDA does not reflect the significant non-cash stock-based compensation expense which should be viewed as a component of recurring operating costs.
These transformation cost adjustments made to our results do not represent normal, recurring, operating expenses necessary to operate the business but rather, incremental costs incurred in connection with our acquisition and integration activities; • Adjusted EBITDA does not reflect goodwill impairment charges; and • Adjusted EBITDA does not reflect the significant non-cash stock-based compensation expense which should be viewed as a component of recurring operating costs.
Cost of revenue is driven primarily by the number of general medical visits, expert medical services, and other specialty visits completed in each period and are closely correlated or directly related to delivery of our solutions and monthly access fees.
Cost of revenue is driven primarily by the number of general medical visits, mental health visits, expert medical services, and other specialty visits completed in each period and are closely correlated or directly related to delivery of our solutions and monthly access fees.
Components of Results of Operations Cost of Revenue (exclusive of depreciation and amortization, which are shown separately) Cost of revenue (exclusive of depreciation and amortization, which are shown separately), or "Cost of revenue," primarily consists of fees paid to the physicians and other health professionals in the THMG Association provider network; product cost; costs incurred in connection with the THMG Association provider network operations and data center activities, which include employee-related expenses (including salaries and benefits, incentive compensation, and stock-based compensation); costs related to Client support; and provider network, medical records, magnetic resonance imaging, medical lab tests, translation, postage, medical malpractice insurance, and deferred device costs.
Components of Results of Operations Cost of Revenue (exclusive of depreciation and amortization, which are shown separately) Cost of revenue (exclusive of depreciation and amortization, which are shown separately), or “Cost of revenue,” primarily consists of fees paid to the physicians and other health professionals in the THMG Association and the Uplift Association provider networks; product cost; costs incurred in connection with the THMG Association and the Uplift Association provider network operations and data center activities, which include employee-related expenses (including salaries and benefits, incentive compensation, and stock-based compensation); costs related to Client support; and provider network, medical records, magnetic resonance imaging, medical lab tests, translation, postage, medical malpractice insurance, and deferred device costs.
Our future capital requirements will depend on many factors including our growth rate, contract renewal activity, number of visits, our ability to retain and/or obtain new members, the timing and extent of spending to support product development efforts, our expansion of sales and marketing activities, the introduction of new and enhanced services offerings, the continuing market acceptance of telehealth, and our debt service obligations.
Our future capital requirements will depend on many factors including our growth rate, contract renewal activity, number of visits, our ability to retain and/or obtain new members, the timing and extent of spending to support product development efforts, our expansion of sales and marketing activities, the introduction of new and enhanced services offerings, the continuing market acceptance of virtual care, and our debt service obligations.
For contracts where revenue is generated on a per healthcare visit basis, revenues are recognized when the visits are completed as we have delivered on our stand ready obligation to provide access.
For contracts where revenue is generated on a per-telehealth visit basis, revenues are recognized when the visits are completed as we have delivered on our stand ready obligation to provide access.
Management’s Discussion and Analysis of Financial Condition and Results of Operations Discussion and analysis of our fiscal year 2022, as well as the year-over-year comparison of our 2023 financial performance to 2022, have been omitted from this section and may be found under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 that was filed with the SEC on February 23, 2024.
Management’s Discussion and Analysis of Financial Condition and Results of Operations Discussion and analysis of our fiscal year 2023, as well as the year-over-year comparison of our 2024 financial performance to 2023, have been omitted from this section and may be found under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 that was filed with the SEC on February 27, 2025.
Integrated Care Segment As it relates to the Integrated Care segment, we primarily generate virtual healthcare service revenue from contracts with Clients who purchase access to the THMG Association professional provider network or medical experts for their employees, dependents and other beneficiaries.
Integrated Care Segment As it relates to the Integrated Care segment, we primarily generate virtual care service revenue from contracts with Clients who purchase access to the THMG Association's professional provider network or medical experts for their employees, dependents and other beneficiaries.
During 2024, we experienced positive operating cash flow and we also anticipate continuing positive operating cash flows for 2025. We believe that our existing cash and cash equivalents will be sufficient to meet our working capital, capital expenditure, and contractual obligation needs for at least the next 12 months.
During 2025, we experienced positive operating cash flow and we anticipate continuing positive operating cash flows for 2026. We believe that our existing cash and cash equivalents will be sufficient to meet our working capital, capital expenditure, and contractual obligation needs for at least the next 12 months.
This principle is achieved through applying the following five-step approach: • Identification of the contract, or contracts, with a Client. • Identification of the performance obligations in the contract. 57 Table of Contents • Determination of the transaction price. • Allocation of the transaction price to the performance obligations in the contract. • Recognition of revenue when, or as, we satisfy a performance obligation.
This principle is achieved through applying the following five-step approach: • Identification of the contract, or contracts, with a Client. • Identification of the performance obligations in the contract. • Determination of the transaction price. • Allocation of the transaction price to the performance obligations in the contract. • Recognition of revenue when, or as, we satisfy a performance obligation.
Marketing costs also include third-party independent research, trade shows and brand messages, public relations costs, and stock-based compensation for our advertising and marketing employees. Our advertising and marketing expenses exclude certain allocations of occupancy expense as well as depreciation and amortization.
Marketing costs also include third-party independent research, trade shows 62 Table of Contents and brand messages, public relations costs, and stock-based compensation for our advertising and marketing employees. Our advertising and marketing expenses exclude certain allocations of occupancy expense as well as depreciation and amortization.
Average Monthly Revenue Per U.S. Integrated Care Member . Average monthly revenue per U.S. Integrated Care member measures the average monthly amount of global revenue that we generate from a U.S. Integrated Care member for a particular period. It is calculated by dividing the total revenue generated from the Integrated Care segment by the average number of U.S.
Integrated Care Member . Average monthly revenue per U.S. Integrated Care member measures the average monthly amount of global revenue that we generate from a U.S. Integrated Care member for a particular period. It is calculated by dividing the total revenue generated from the Integrated Care segment by the average number of U.S. Integrated Care members during the applicable period.
Interest and penalties, if any, related to accrued liabilities for potential tax assessments are included in income tax expense. 60 Table of Contents Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized.
Interest and penalties, if any, related to accrued liabilities for potential tax assessments are included in income tax expense. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized.
Adjusted EBITDA consists of net loss before provision for income taxes; other expense (income), net; interest income; interest expense; depreciation of property and equipment; amortization of intangible assets; restructuring costs; acquisition, integration, and transformation cost; goodwill impairment; and stock-based compensation. Free cash flow is net cash provided by operating activities less capital expenditures and capitalized software development costs.
Adjusted EBITDA consists of net loss before provision for income taxes; other expense (income), net; interest income; interest expense; depreciation of property and equipment; amortization of intangible assets; restructuring costs; acquisition, integration, and transformation cost; goodwill impairments; and stock-based compensation. 64 Table of Contents Free cash flow is net cash provided by operating activities less capital expenditures and capitalized software development costs.
We have elected the optional exemption to not disclose the remaining performance obligations of our contracts since the majority of our contracts have a duration of one year or less and the variable consideration expected to be received over the duration of the contract is allocated entirely to the wholly unsatisfied performance obligations.
We have elected the practical expedient to not disclose the remaining performance obligations of our contracts since the majority of our contracts have a duration of one year or less and the variable consideration expected to be received over the duration of the contract is allocated entirely to the wholly unsatisfied performance obligations.
If the carrying value of the asset group is determined to be unrecoverable, an impairment charge would be recognized in an amount equal to the amount by which the carrying value of the asset group exceeds its fair value.
If the carrying value of the asset group is determined to be unrecoverable, an 61 Table of Contents impairment charge would be recognized in an amount equal to the amount by which the carrying value of the asset group exceeds its fair value.
The decrease was primarily driven by lower employee compensation costs, partially offset by higher infrastructure, hosting, and software license costs associated with running operations as well as ongoing projects and services to continuously improve and optimize our products and services. For the years ended December 31, 2024 and 2023, research and development costs were $89.1 million and $124.6 million, respectively.
The decrease was primarily driven by lower employee compensation costs, partially offset by higher infrastructure, hosting, and software license costs associated with running operations as well as ongoing projects and services to continuously improve and optimize our products and services. For the years ended December 31, 2025 and 2024, research and development costs were $88.5 million and $89.1 million, respectively.
We further believe that increasing our membership is an integral objective that will provide us with the ability to continually innovate our services and support initiatives that will enhance members’ experiences.
We further believe that increasing our membership is an integral objective that will provide us with the ability to continually innovate our services 57 Table of Contents and support initiatives that will enhance members’ experiences.
The Company has two reporting units, which are the same as its reportable segments: Teladoc Health Integrated Care and BetterHelp. As of December 31, 2024, our balance of goodwill was $283.2 million, which all related to the BetterHelp segment.
The Company has two reporting units, which are the same as its reportable segments: Teladoc Health Integrated Care and BetterHelp. 60 Table of Contents As of December 31, 2025, our balance of goodwill was $283.2 million, which all related to the BetterHelp segment.
Integrated Care member decreased to $1.37 in the year ended December 31, 2024, from $1.41 in the same period in 2023, primarily due to the impact of new members onboarded over the course of the year.
Integrated Care member decreased to $1.29 in the year ended December 31, 2025, from $1.37 in the same period in 2024, primarily due to the impact of new members onboarded over the course of the year.
BetterHelp paying users decreased by 11% to 0.41 million for the year ended December 31, 2024, compared to 0.46 million for the year ended December 31, 2023. As it relates to the Company: Seasonality. Our business has historically been subject to seasonality.
BetterHelp paying users decreased by 5% to 0.39 million for the year ended December 31, 2025, compared to 0.41 million for the year ended December 31, 2024. As it relates to the Company: Seasonality. Our business has historically been subject to seasonality.
Item 6. [Reserved] Not applicable. 55 Table of Contents Item 7.
Item 6. [Reserved] Not applicable. 56 Table of Contents Item 7.
U.S. Integrated Care members increased by 4.2 million, or 5%, to 93.8 million at December 31, 2024, compared to the same period in 2023. Chronic Care Program Enrollment . Chronic care program enrollment represents the total number of enrollees across our suite of chronic care programs at the end of a given period.
U.S. Integrated Care members increased by 8.0 million, or 9%, to 101.8 million at December 31, 2025, compared to the same period in 2024. Chronic Care Program Enrollment . Chronic care program enrollment represents the total number of enrollees across our suite of chronic care programs at the end of a given period.
The change in average monthly revenue versus the indicated prior period is reflective of the growth and timing of onboarding new members and the mix of their fees. As it relates to the BetterHelp segment: BetterHelp Paying Users . BetterHelp paying users represent the average number of global monthly paying users of our BetterHelp therapy services during the applicable period.
The change in average monthly revenue versus the indicated prior period is reflective of the growth and timing of onboarding new members and the mix of their fees. As it relates to the BetterHelp segment: BetterHelp Paying Users .
Restructuring Costs . Restructuring costs were $20.4 million and $16.9 million for the years ended December 31, 2024 and 2023, respectively. The costs primarily related to the reduction of office space, severance, right-of-use asset impairment charges and other restructuring related costs. See Note 12. ‘Restructuring” to the financial statements for additional information. Amortization of Intangible Assets.
Restructuring costs were $18.8 million and $20.4 million for the years ended December 31, 2025 and 2024, respectively. The costs primarily related to severance, the reduction of office space, right-of-use asset impairment charges, and other restructuring related costs. See Note 13. “Restructuring” to the financial statements for additional information.
Technology and development expenses also include outsourced software engineering services, the costs of operating our on-demand technology infrastructure (whereas costs directly associated with revenue are presented separately in cost of revenues), and certain licensed applications. Our technology and development expenses exclude capitalized software development costs and depreciation and amortization.
Technology and development expenses also include outsourced software engineering services, the costs of operating our on-demand technology infrastructure (whereas costs directly associated with revenue are presented separately in cost of revenues), certain licensed applications, and stock-based compensation for its technology and development employees.
These contracts also include multiple performance obligations, and we determine the standalone selling prices based on overall pricing objectives. In some arrangements, our devices are rented to certain qualified Clients that qualify as either sales-type lease or operating lease arrangements and are subject to lease accounting guidance.
These contracts also include multiple performance obligations, and we determine the standalone selling prices based on historical selling price of these performance obligations in similar transactions as well as current pricing practices. In some arrangements, devices are rented to certain Clients that qualify as either sales-type lease or operating lease arrangements and are subject to lease accounting guidance.
It also includes costs related to certain business transformation initiatives focused on integrating and optimizing various operations and systems, including upgrading our CRM and ERP systems, incurred in connection with our acquisition and integration activities. Amortization of Intangible Assets Amortization of intangible assets consists of the amortization of capitalized software development costs and of acquisition-related intangible assets.
It also includes costs related to certain business transformation initiatives focused on 63 Table of Contents integrating and optimizing various operations and systems, including upgrading our CRM and ERP systems, incurred in connection with our acquisition and integration activities.
Restructuring Costs Restructuring costs consist primarily of lease impairment costs, losses related to the reduction of office space, and costs for employee transition, severance payments, employee benefits, and related costs.
Restructuring Costs Restructuring costs consist primarily of lease impairment costs, losses related to the reduction of office space, and costs for employee transition, severance payments, employee benefits, and related costs. Amortization of Intangible Assets Amortization of intangible assets consists of the amortization of capitalized software development costs and of acquisition-related intangible assets.
BetterHelp advertising and marketing, exclusive of stock-based compensation increased by $16.9 million, or 3%, to $558.8 million for the year ended December 31, 2024, primarily reflecting higher spending on digital and media advertising. BetterHelp other segment expenses decreased by $9.4 million, or 7%, to $132.6 million for the year ended December 31, 2024.
BetterHelp advertising and marketing, exclusive of stock-based compensation decreased by $40.3 million, or 7%, to $518.5 million for the year ended December 31, 2025, primarily reflecting lower spending on digital and media advertising. BetterHelp other segment expenses increased by $4.3 million, or 3%, to $136.9 million for the year ended December 31, 2025.
Visit and other revenues are reported as “Other” revenue in our consolidated financial statements. Revenue is also generated from contracts with Clients in hospital and health systems for the sale and rental of equipment consisting of virtual healthcare devices which allow physicians to access our hosted virtual healthcare platform.
Revenue is also generated from contracts with Clients in hospital and health systems for the sale and rental of equipment consisting of virtual care devices which allow physicians to access our hosted virtual care platform.
The research and development expenses may enable future revenue growth but are not directly related to current revenues. 61 Table of Contents Technology and development expenses include personnel and related expenses (including salaries and benefits, incentive compensation, and stock-based compensation) for software engineering, information technology infrastructure, security and compliance, product development, and support for our efforts to add new features and ensure the reliability or scalability of our existing solutions.
Technology and development expenses include personnel and related expenses (including salaries and benefits, incentive compensation, and stock-based compensation) for software engineering, information technology infrastructure, security and compliance, product development, and support for our efforts to add new features and ensure the reliability or scalability of our existing solutions.
Liquidity and Capital Resources The following table presents a summary of our cash flow activity for the years ended December 31, 2024 and 2023 (in thousands): Year Ended December 31, Consolidated Statements of Cash Flows - Summary 2024 2023 Net cash provided by operating activities $ 293,680 $ 350,021 Net cash used in investing activities (124,052) (156,347) Net cash provided by financing activities 8,312 10,854 Effect of foreign currency exchange rate changes (3,288) 965 Total increase in cash and cash equivalents $ 174,652 $ 205,493 Our principal source of liquidity is our cash and cash equivalents, totaling $1,298.3 million as of December 31, 2024.
Liquidity and Capital Resources The following table presents a summary of our cash flow activity for the years ended December 31, 2025 and 2024 (in thousands): Year Ended December 31, Consolidated Statements of Cash Flows - Summary 2025 2024 Net cash provided by operating activities $ 294,357 $ 293,680 Net cash used in investing activities (266,003) (124,052) Net cash (used in) provided by financing activities (551,652) 8,312 Effect of foreign currency exchange rate changes 6,055 (3,288) Total (decrease) increase in cash and cash equivalents $ (517,243) $ 174,652 70 Table of Contents Our principal source of liquidity is our cash and cash equivalents, totaling $781.1 million as of December 31, 2025.
The decrease was primarily driven by lower employee compensation, partially offset by higher professional fees and broker commissions. Technology and Development Expenses. Technology and development expenses were $307.3 million for the year ended December 31, 2024, compared to $348.5 million for the year ended December 31, 2023, a decrease of $41.2 million, or 12%.
Sales expenses were $194.5 million for the year ended December 31, 2025, compared to $205.0 million for the year ended December 31, 2024, a decrease of $10.5 million, or 5%. The decrease was primarily driven by lower employee compensation costs and lower professional fees, partially offset by higher broker commissions. Technology and Development Expenses.
BetterHelp cost of revenue, exclusive of depreciation, amortization, and stock-based compensation decreased by $42.0 million, or 13%, to $271.5 million for the year ended December 31, 2024. The decrease was primarily driven by lower therapist costs.
BetterHelp cost of revenue, exclusive of depreciation, amortization, and stock-based compensation decreased by $18.3 million, or 7%, to $253.2 million for the year ended December 31, 2025. The decrease was primarily driven by lower therapist costs.
Additionally, certain of our contracts include Client performance guarantees and pricing adjustments that are based upon minimum member utilization and guarantees by us for specific service level performance, member satisfaction 58 Table of Contents scores, cost savings or other value achievements or guarantees, and health outcome guarantees.
Our contracts do not generally contain refund provisions for fees earned related to services performed. Additionally, certain of our contracts include Client performance guarantees and pricing adjustments that are based upon minimum member utilization and guarantees by us for specific service level performance, member satisfaction scores, cost savings or other value achievements or guarantees, and health outcome guarantees.
Our chronic care program enrollments are one of the key components of our virtual care platform that we believe positions us to drive greater engagement with our platforms 56 Table of Contents and increased revenue. Chronic care program enrollment increased by 4% to 1.20 million at December 31, 2024, compared to 1.16 million at December 31, 2023.
Our chronic care program enrollments are one of the key components of our virtual care platform that we believe positions us to drive greater engagement with our platforms and increase revenue. Chronic care program enrollment decreased by 1% to 1.19 million at December 31, 2025, compared to 1.20 million at December 31, 2024. Average Monthly Revenue Per U.S.
We recorded income tax expense of $7.6 million for the year ended December 31, 2024, compared to $0.8 million for the year ended December 31, 2023.
We recorded income tax benefit of $35.2 million for the year ended December 31, 2025, compared to an income tax expense of $7.6 million for the year ended December 31, 2024.
The majority of Clients have a term of one year and renew their contracts following their first year of services. Revenues are recognized when we satisfy our performance obligation to stand ready to provide virtual healthcare services which occurs when our Clients and members have access to and obtain control of the virtual healthcare service or platform.
Revenues are recognized when we satisfy our performance obligation to stand ready to 59 Table of Contents provide virtual care services which occurs when our Clients and members have access to and obtain control of the virtual care service or platform.
These services are consumed as they are received, and we recognize revenue each month using the variable consideration allocation exception since the nature of the obligations and the variability of the payment being based on the number of active members are aligned. Our Client agreements generally have a term of one to three years for the Integrated Care segment.
These services are consumed as they are received, and we recognize revenue each month using the variable consideration allocation exception because the nature of the obligations and the variability of the payment being based on the number of active members are aligned.
This increase was substantially driven by higher media advertising costs, partially offset by lower employee compensation costs. Sales Expenses. Sales expenses were $205.0 million for the year ended December 31, 2024, compared to $213.8 million for the year ended December 31, 2023, a decrease of $8.8 million, or 4%.
Advertising and marketing expenses were $653.4 million for the year ended December 31, 2025, compared to $705.8 million for the year ended December 31, 2024, a decrease of $52.4 million, or 7%. This decrease was driven by lower media advertising and employee compensation costs. Sales Expenses.
Our Client contracts include a PMPM access fee as well as certain contracts that also include additional revenue on a per-virtual healthcare visit basis for general medical, or other specialty visits or expert medical service on a per case basis.
Our Client contracts include a PMPM, PEPM, or PPPM access fee as well as certain contracts that generate revenue based solely on a per-telehealth visit basis for general medical and other specialty visits.
General and Administrative Expenses. General and administrative expenses were $435.5 million for the year ended December 31, 2024, compared to $464.7 million for the year ended December 31, 2023, a decrease of $29.2 million, 65 Table of Contents or 6%.
General and Administrative Expenses. General and administrative expenses were $431.9 million for the year ended December 31, 2025, compared to $435.5 million for the year ended December 31, 2024, a decrease of $3.6 million, or 1%.
Unless the context otherwise requires, Teladoc Health, Inc., together with its subsidiaries, is referred to herein as “Teladoc Health,” the “Company,” or “we.” The Company’s principal executive office is located in Purchase, New York. Teladoc Health is the global leader in virtual care focused on forging a new healthcare experience with better convenience, outcomes, and value around the world.
Unless the context otherwise requires, Teladoc Health, Inc., together with its subsidiaries, is referred to herein as “Teladoc Health,” the “Company,” or “we.” In June 2025, the Company relocated its principal executive office from Purchase, New York to New York, New York. Teladoc Health is the global leader in virtual care.
We believe that our ability to increase the revenue generated from each member over time is also a key indicator of our increasing market adoption, the growth of our business, and future revenue potential. Average monthly revenue per U.S.
Approximately 20% of total Integrated Care revenues relates to international and hospital and health systems for which membership is not considered as a management metric. We believe that our ability to increase the revenue generated from each member over time is also a key indicator of our increasing market adoption and future revenue growth potential. Average monthly revenue per U.S.
Depreciation of Property and Equipment Depreciation of property and equipment consists of the depreciation of fixed assets. Interest Income Interest income primarily consists of interest earned on cash and cash equivalents.
Depreciation of Property and Equipment Depreciation of property and equipment consists of the depreciation of fixed assets. Interest Income Interest income primarily consists of interest earned on cash and cash equivalents. Interest Expense Interest expense consists of interest costs and the amortization of debt discounts primarily associated with convertible senior notes.
In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all, which would adversely affect our business, financial condition, and results of operations. Historically, we have financed our operations primarily through sales of equity securities, debt issuance, and bank borrowings.
In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all, which would adversely affect our business, financial condition, and results of operations. On July 17, 2025, we entered into the five-year, $300.0 million Revolving Credit Facility.
The year-over-year decrease was substantially driven by a decline in operating cash flow, partially offset by a decline in capitalized software.
The year-over-year decrease was substantially driven by an increase in capitalized software development costs, partially offset by a decrease in capital expenditures.
For the years ended December 31, 2024 and 2023, revenue recognized from performance obligations related to prior periods for changes in estimated transaction price or Client performance guarantees was $5.9 million and $14.7 million, respectively.
Performance obligations related to prior periods for changes in estimated transaction price or Client performance guarantees resulted in an increase of $8.3 million in revenue for the year ended December 31, 2025 and a decrease of $5.9 million of revenue for the year ended December 31, 2024.
The decrease was primarily driven by lower therapist recruiting and retention costs, lower employee related costs, and lower credit card processing fees, partially offset by higher legal and regulatory fees and higher software and infrastructure costs.
The increase was primarily driven by higher employee related costs, professional fees, dues and subscriptions, and software and infrastructure costs, partially offset by lower indirect taxes, occupancy and office costs, and credit card processing fees.
The decrease was primarily driven by lower provider and technology costs, partially offset by higher amortization of device costs. Advertising and Marketing Expenses. Advertising and marketing expenses were $705.8 million for the year ended December 31, 2024, compared to $688.9 million for the year ended December 31, 2023, an increase of $16.9 million, or 2%.
Cost of revenue was $771.6 million for the year ended December 31, 2025, compared to $751.3 million for the year ended December 31, 2024, an increase of $20.3 million, or 3%. The increase was primarily driven by higher labor costs, technology costs, and amortization of devices, partially offset by lower provider costs. 67 Table of Contents Advertising and Marketing Expenses.
In evaluating these financial measures, you should be aware that in the future we may incur expenses similar to those eliminated in this presentation. Our presentation of these non-GAAP measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.
In evaluating these financial measures, you should be aware that in the future we may incur expenses similar to those eliminated in this presentation.
We were founded on a simple, yet revolutionary idea: that everyone should have access to the best healthcare, anywhere in the world on their terms.
More than 20 years ago, we were founded on a simple, yet revolutionary idea: that everyone should have access to the best healthcare, anywhere in the world on their terms. Our mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience.
Segment Information The following tables set forth the results of operations by segment for the years ended December 31, 2024 and 2023 (dollars in thousands): Year Ended December 31, Variance % Integrated Care 2024 2023 Revenue $ 1,528,870 $ 1,468,794 $ 60,076 4 % Cost of revenue, exclusive of depreciation, amortization, and stock-based compensation 474,955 440,996 33,959 8 % Other segment expenses (1) 821,013 835,927 (14,914) (2) % Adjusted EBITDA $ 232,902 $ 191,871 $ 41,031 21 % Adjusted EBITDA Margin % 15.2 % 13.1 % _________________________________________ (1) Other segment expenses include advertising and marketing expenses, sales expenses, technology and development expenses, and general and administrative expenses, each exclusive of stock-based compensation.
Segment Information The following tables set forth the results of operations by segment for the years ended December 31, 2025 and 2024 (dollars in thousands): Year Ended December 31, Variance % Integrated Care 2025 2024 Revenue $ 1,579,610 $ 1,528,870 $ 50,740 3 % Cost of revenue, exclusive of depreciation, amortization, and stock-based compensation 516,326 474,955 41,371 9 % Advertising and marketing, exclusive of stock-based compensation 130,023 134,453 (4,430) (3) % Other segment expenses (1) 694,039 686,560 7,479 1 % Adjusted EBITDA $ 239,222 $ 232,902 $ 6,320 3 % Adjusted EBITDA Margin % 15.1% 15.2% (1) Other segment expenses include sales expenses, technology and development expenses, and general and administrative expenses, each exclusive of stock-based compensation.
The following table shows amortization of intangible assets broken down by components for the periods indicated (in thousands): Year Ended December 31, 2024 2023 % Amortization of acquired intangibles $ 230,328 $ 242,976 (5) % Amortization of capitalized software development costs 133,037 82,957 60 % Amortization of intangible assets expense $ 363,365 $ 325,933 11 % Amortization of intangible assets was $363.4 million for the year ended December 31, 2024, compared to $325.9 million for the year ended December 31, 2023, an increase of $37.4 million, or 11%.
The following table shows amortization of intangible assets broken down by components for the periods indicated (in thousands): Year Ended December 31, 2025 2024 % Amortization of acquired intangibles $ 183,147 $ 230,328 (20) % Amortization of capitalized software development costs 167,617 133,037 26 % Amortization of intangible assets $ 350,764 $ 363,365 (3) % 68 Table of Contents Amortization of intangible assets was $350.8 million for the year ended December 31, 2025, compared to $363.4 million for the year ended December 31, 2024, a decrease of $12.6 million, or 3%.
Consolidated Results of Operations The following table sets forth our consolidated statement of operations data for the years ended December 31, 2024 and 2023 and the dollar and percentage change between the respective periods (dollars in thousands, except per share data).
Our presentation of these non-GAAP measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items. 65 Table of Contents Consolidated Results of Operations The following table sets forth our consolidated statement of operations data for the years ended December 31, 2025 and 2024 and the dollar and percentage change between the respective periods (dollars in thousands, except per share data).
Goodwill Goodwill represents the excess of the total purchase consideration over the fair value of the identifiable assets acquired and liabilities assumed in a business combination.
We issued refunds of approximately $49.9 million and $84.0 million for the years ended December 31, 2025 and 2024, respectively. Goodwill Goodwill represents the excess of the total purchase consideration over the fair value of the identifiable assets acquired and liabilities assumed in a business combination.
Integrated Care cost of revenue, exclusive of depreciation, amortization, and stock-based compensation, increased by $34.0 million, or 8%, to $475.0 million for the year ended December 31, 2024. The increase was primarily driven by higher provider costs and amortization of device costs, partially offset by lower technology costs.
The increase was primarily driven by higher provider costs, technology costs, and amortization of device costs. 69 Table of Contents Integrated Care advertising and marketing, exclusive of stock-based compensation, decreased by $4.4 million, or 3%, to $130.0 million for the year ended December 31, 2025, primarily reflecting lower spending on digital and media advertising and marketing.
As of December 31, 2024, the aggregate balance of these assets was $1,431.4 million. We amortize these definite-lived intangible assets over their estimated useful lives as disclosed in Note 8. “Intangible Assets, Net and Certain Cloud Computing Costs” to the consolidated financial statements.
We amortize these definite-lived intangible assets over their estimated useful lives as disclosed in Note 9. “Intangible Assets, Net and Certain Cloud Computing Costs” to the consolidated financial statements. We also review the estimated useful lives on a quarterly basis to determine if the period of economic benefit has changed.
Integrated Care other segment expenses decreased by $14.9 million, or 2%, to $821.0 million for the year ended December 31, 2024. The decrease was primarily driven by lower employee compensation, partially offset by higher software and infrastructure costs, legal and regulatory costs, and advertising costs, as well as higher commissions and professional fees.
Integrated Care other segment expenses increased by $7.5 million to $694.0 million for the year ended December 31, 2025. The increase was primarily driven by higher indirect taxes, software and infrastructure costs, commissions costs, and dues and subscriptions, partially offset by lower employee compensation.
The following is a reconciliation of net cash provided by operating activities to free cash flow (in thousands, unaudited): Year Ended December 31, 2024 2023 Net cash provided by operating activities $ 293,680 $ 350,021 Capital expenditures (10,790) (11,464) Capitalized software development costs (113,262) (144,884) Free Cash Flow $ 169,628 $ 193,673 Free cash flow was $169.6 million for the year ended December 31, 2024, as compared to $193.7 million for the year ended December 31, 2023.
Cash provided by financing activities for the year ended December 31, 2024 was $8.3 million and primarily consisted of $3.6 million of proceeds from the exercise of employee stock options and $4.7 million of proceeds from participants in our employee stock purchase plan. 71 Table of Contents Free Cash Flow The following is a reconciliation of net cash provided by operating activities to free cash flow (in thousands, unaudited): Year Ended December 31, 2025 2024 Net cash provided by operating activities $ 294,357 $ 293,680 Capital expenditures (8,893) (10,790) Capitalized software development costs (118,562) (113,262) Free Cash Flow $ 166,902 $ 169,628 Free cash flow was $166.9 million for the year ended December 31, 2025, as compared to $169.6 million for the year ended December 31, 2024.
Other expense (income), net was an expense of $6.0 million for the year ended December 31, 2024, compared to an income of $4.4 million for the year ended December 31, 2023, primarily reflecting losses on foreign currency exchange rate fluctuations for the year ended December 31, 2024, whereas the year ended December 31, 2023 reflected a gain on the partial sale of a business, partially offset by losses on foreign currency exchange rate fluctuations. 66 Table of Contents Provision for Income Taxes .
Other expense (income), net was an income of $10.4 million for the year ended December 31, 2025, compared to an expense of $6.0 million for the year ended December 31, 2024. The balance in both periods primarily reflects the impact of foreign currency exchange rate fluctuations. Provision for Income Taxes .
Critical Accounting Estimates and Policies Revenue We follow the revenue accounting requirements of Accounting Standards Codification (“ASC”) Topic 606, which establishes a principle for recognizing revenue upon the transfer of promised goods or services to customers, in an amount that reflects the expected consideration received in exchange for those goods or services.
See “Risk Factors—Risks Related to Our Business and Industry—Our quarterly results may fluctuate significantly, which could adversely impact the value of our common stock.” included elsewhere in this Annual Report on Form 10-K. 58 Table of Contents Critical Accounting Estimates and Policies Revenue We follow the revenue accounting requirements of Accounting Standards Codification (“ASC”) Topic 606, “Revenues from Contracts with Customers,” which establishes a principle for recognizing revenue upon the transfer of promised goods or services to customers, in an amount that reflects the expected consideration received in exchange for those goods or services.
The increase was primarily driven by an increase in the average cash and cash equivalent balance. Interest Expense. Interest expense was $23.8 million for the year ended December 31, 2024, compared to $22.3 million for the year ended December 31, 2023. Other Expense (Income), Net.
Interest expense was $19.7 million for the year ended December 31, 2025, compared to $23.8 million for the year ended December 31, 2024. The decrease was driven by the maturation of the Livongo Notes and 2025 Notes. Other Expense (Income), Net.
We routinely enter into contractual obligations with third parties to provide professional services, licensing, and other products and services in support of our ongoing business.
We routinely enter into contractual obligations with third parties to provide professional services, licensing, and other products and services in support of our ongoing business. The current estimated cost of these contracts is not expected to be significant to our liquidity and capital resources based on contracts in place as of December 31, 2025.
The primary uses of cash from operating activities are for the payment of cash compensation, provider fees, engagement marketing, direct-to-consumer digital and media advertising, inventory, insurance, technology costs, interest expense and acquisition, integration, and transformation costs. Historically, cash compensation is at its highest level in the first quarter when discretionary employee compensation related to the previous fiscal year is paid.
The increase was driven by higher collections from customers and lower incentive compensation payments, offset by higher operational spending. The primary uses of cash from operating activities are for the payment of cash compensation, provider fees, engagement marketing, direct-to-consumer digital and media advertising, inventory, insurance, technology costs, interest expense and acquisition, integration, and transformation costs.
The higher expense was driven by an increase in the amortization of capitalized software development costs related to our investment in platforms, partially offset by lower amortization of acquired intangibles due to certain trademarks becoming fully amortized.
The decrease was primarily driven by the lower amortization associated with the Livongo trademark, partially offset by an increase in the amortization of capitalized software development costs related to our investment in platforms. Depreciation of Property and Equipment.
For other wellness services, users can purchase access to their consumer application for a subscription fee, generally for a period of one year. BetterHelp also provides virtual therapy services to employers as part of employee assistance programs, with revenues recorded based on completion of visit. The BetterHelp service provides for member refunds.
BetterHelp also provides virtual therapy services to employers as part of employee assistance programs, with revenues recorded based on completion of visit. The BetterHelp service provides for member refunds. We estimate the expected amount of refunds to be issued based on historical experience, which are recorded as a reduction of revenue.
“Goodwill,” to our consolidated financial statements for further information. At October 1, 2024, we performed our annual test of goodwill impairment using a quantitative analysis. We determined that the BetterHelp reporting unit’s fair value exceeded its carrying value by a significant margin, while the Integrated Care reporting unit’s fair value was less than its carrying value.
At October 1, 2025, we performed our annual test of goodwill impairment using a discounted cash flow method under the income approach. We determined that the BetterHelp reporting unit’s fair value exceeded its carrying value, while the Integrated Care reporting unit’s fair value approximated its carrying value.
Interest Expense Interest expense consists of interest costs and the amortization of debt discounts primarily associated with convertible senior notes. 62 Table of Contents Other Expense (Income), Net Other expense (income), net includes the impact of foreign currency remeasurement, realized gains on investment securities, and all other non-operating items not included in other financial statement lines.
Other Expense (Income), Net Other expense (income), net includes the impact of foreign currency remeasurement, realized gains on investment securities, and all other non-operating items not included in other financial statement lines. Provision for Income Taxes Provision for income taxes reflects management’s best assessment of estimated current and future taxes to be paid.
Since the BetterHelp reporting unit's fair value exceeded its carrying value and the Integrated Care reporting unit carries no goodwill at October 1, 2024, no impairment was recorded. On January 31, 2025, we signed a definitive agreement to acquire Catapult Health, LLC (“Catapult Health”) that we expect to close during the three months ending March 31, 2025.
Since the BetterHelp reporting unit's fair value exceeded its carrying value and the Integrated Care reporting unit carried no goodwill at October 1, 2025, no impairment was recorded.
For additional information on the acquisition of Catapult Health, see Note 19. "Subsequent Events" to the consolidated financial statements. 59 Table of Contents Other Intangible Assets Other intangible assets include customer relationships, non-compete agreements, acquired technology, and trademarks resulting from business acquisitions, as well as capitalized software development costs.
“Goodwill” to our consolidated financial statements for further information. Other Intangible Assets Other intangible assets include client and other relationships, acquired technology, and trademarks resulting from business acquisitions, as well as capitalized software development costs. As of December 31, 2025, the aggregate balance of these assets was $1,297.1 million.
Depreciation of property and equipment was $10.2 million for the year ended December 31, 2024, compared to $11.1 million for the year ended December 31, 2023, a decrease of $1.0 million, or 9%. Interest Income. Interest income was $57.1 million for the year ended December 31, 2024, compared to $46.8 million for the year ended December 31, 2023.
Interest income was $36.8 million for the year ended December 31, 2025, compared to $57.1 million for the year ended December 31, 2024. The decrease was driven by a lower average balance of cash and cash equivalents and lower interest rate yields. Interest Expense.
We record access fees from Clients accessing the THMG Association professional provider network or hosted virtual healthcare platform or chronic care management platforms, visit fee revenue for general medical, expert medical service and other specialty visits as well as other revenue primarily associated with virtual healthcare device equipment included with our hosted virtual healthcare platform.
Depending on the product, we may generate revenue from Clients through a combination of access fees and visit fees, while certain Clients may have access-fee only or visit fee only arrangements. We generate access fees from Clients accessing the THMG Association professional provider network, hosted virtual care platform, and chronic care management platforms.
The current estimated cost of these contracts is not expected to be significant to our liquidity and capital resources based on contracts in place as of December 31, 2024. 68 Table of Contents Cash from Operating Activities Cash flows provided by operating activities consisted of net loss adjusted for certain non-cash items and the cash effect of changes in assets and liabilities.
Cash from Operating Activities Cash flows provided by operating activities consisted of net loss adjusted for certain non-cash items and the cash effect of changes in assets and liabilities. Cash provided by operating activities was $294.4 million and $293.7 million for the years ended December 31, 2025 and 2024, respectively, reflecting an increase of $0.7 million.
Year Ended December 31, Variance % BetterHelp 2024 2023 Therapy Services $ 1,017,725 $ 1,116,693 $ (98,968) (9) % Other Wellness Services 22,979 16,928 6,051 36 % Total Revenue 1,040,704 1,133,621 (92,917) (8) % Cost of revenue, exclusive of depreciation, amortization, and stock-based compensation 271,533 313,572 (42,039) (13) % Advertising and marketing, exclusive of stock-based compensation 558,759 541,815 16,944 3 % Other segment expenses (1) 132,603 141,985 (9,382) (7) % Adjusted EBITDA $ 77,809 $ 136,249 $ (58,440) (43) % Adjusted EBITDA Margin % 7.5 % 12.0 % _________________________________________ (1) Other segment expenses include sales expenses, technology and development expenses, and general and administrative expenses, each exclusive of stock-based compensation. 67 Table of Contents BetterHelp total revenues decreased by $92.9 million, or 8%, to $1,040.7 million for the year ended December 31, 2024, driven by an 11% decrease in average monthly paying users.
Year Ended December 31, Variance % BetterHelp 2025 2024 Therapy Services $ 930,700 $ 1,017,725 $ (87,025) (9) % Other Wellness Services 19,667 22,979 (3,312) (14) % Total Revenue $ 950,367 $ 1,040,704 (90,337) (9) % Cost of revenue, exclusive of depreciation, amortization, and stock-based compensation 253,185 271,533 (18,348) (7) % Advertising and marketing, exclusive of stock-based compensation 518,455 558,759 (40,304) (7) % Other segment expenses (1) 136,854 132,603 4,251 3 % Adjusted EBITDA $ 41,873 $ 77,809 $ (35,936) (46) % Adjusted EBITDA Margin % 4.4% 7.5% (1) Other segment expenses include sales expenses, technology and development expenses, and general and administrative expenses, each exclusive of stock-based compensation.
During the second half of 2023, we initiated a strategy to transition the majority of our chronic condition management Clients and members to the Teladoc Health brand on a phased basis, with a smaller subset continuing to be served under the Livongo trade name beyond 2024.
During the three months ended December 31, 2025, we initiated a strategy to transition the remainder of our chronic condition management Clients and members to the Teladoc Health brand by December 31, 2026.